相关实验视频

Updated: Jul 1, 2025

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model

Published on: December 10, 2021

炎症作为关联:探索急性心肌梗塞和慢性阻塞性肺病之间的联系

Eloise Marriott¹, Aran Singanayagam², Juma El-Awaisi¹

¹Microcirculation Research Group, Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

Frontiers in cardiovascular medicine

|March 7, 2024

概括

慢性阻塞性肺病 (COPD) 和急性心肌梗塞 (AMI) 具有相同的炎症途径. 了解这种血栓炎症交叉是治疗并发病患者和改善治疗结果的关键.

科学领域:

心脏病学心脏病学
肺部病理学肺部病理学
免疫学免疫学免疫学

背景情况:

急性心肌梗塞 (AMI) 和慢性阻塞性肺病 (COPD),特别是在急性恶化 (AE-COPD) 期间,共享重叠的炎症机制.
虽然AMI和COPD的个体炎症途径得到了充分的研究,但它们在并发性疾病中的相互作用尚未完全理解.
针对炎症的现有治疗方法对个体疾病有希望,但它们在联合AMI和COPD中的有效性尚未被证明.

研究的目的:

审查局部和全身炎症作为AMI和COPD/AE-COPD之间的病理生理联系的关键作用.
为了突出人们对AMI和COPD患者的血栓炎性交叉通话的有限理解.
强调需要进一步研究抗炎策略在这种并发症患者群体中的有效性.

主要方法:

文献综述侧重于AMI和COPD的炎症机制.
在并发症环境中研究血栓炎症的研究分析.
综合当前关于共享炎症通路的知识.

主要成果:

炎症是AMI和COPD/AE-COPD之间的主要病理生理联系.
在驱动这两种疾病的炎症机制中存在显著的重叠.
结合性AMI和COPD中血栓炎性交叉的特定影响需要进一步调查.

结论:

局部和全身炎症在AMI和COPD/AE-COPD之间的病理生理学中至关重要.
需要进行进一步的研究,以确定针对伴随性AMI和COPD患者的炎症组件的疗效.
了解血栓-炎症交叉是开发高风险人群有效治疗的必要条件.

关键词:

S100A8 / A9 / A9 / S100A8 / A9 / S100A8 / A9 / S100A8 / A9 / S100A9 / S100A8 / S100A9 / S100A8 / S100A9 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A9 / S100A8 / S100A9 / S100A9 / S100A8 / S100A8 / S100A9 / S100A8 / S100A9 / S100A8 / S100A9 / S100A8 / S100A9 / S100A8 / S100A9 / S100A9 / S100A8 / S100A8 / S100A8 / S100A9 / S100A8 / S100A9 剧烈的心肌梗塞急性心肌梗塞这是一种抗炎药物.慢性阻塞性肺病慢性阻塞性肺病这是一种炎症炎症炎症炎症.它们包括interleukins.

更多相关视频

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Inflammation

Inflammation